0000905729-24-000142.txt : 20240820 0000905729-24-000142.hdr.sgml : 20240820 20240820112519 ACCESSION NUMBER: 0000905729-24-000142 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240820 DATE AS OF CHANGE: 20240820 EFFECTIVENESS DATE: 20240820 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cirius Therapeutics, Inc. CENTRAL INDEX KEY: 0001702956 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 820928811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-521970 FILM NUMBER: 241223562 BUSINESS ADDRESS: STREET 1: 3133 ORCHARD VISTA DR. SW CITY: GRAND RAPIDS STATE: MI ZIP: 48390 BUSINESS PHONE: 616-450-5552 MAIL ADDRESS: STREET 1: 3133 ORCHARD VISTA DR. SW CITY: GRAND RAPIDS STATE: MI ZIP: 48390 D 1 primary_doc.xml X0708 D LIVE 0001702956 Cirius Therapeutics, Inc. 3133 ORCHARD VISTA DR. SW GRAND RAPIDS MI MICHIGAN 48390 616-450-5552 DELAWARE None None Corporation true Mark Olesnavage 3133 Orchard Vista Drive SW Grand Rapids MI MICHIGAN 48390 Executive Officer Jerry Callahan 3133 Orchard Vista Drive SW Grand Rapids MI MICHIGAN 48390 Executive Officer Michael Jandernoa 3133 Orchard Vista Drive SW Grand Rapids MI MICHIGAN 48390 Director David Van Andel 3133 Orchard Vista Drive SW Grand Rapids MI MICHIGAN 48390 Director Robert Zerbe 3133 Orchard Vista Drive SW Grand Rapids MI MICHIGAN 48390 Director Biotechnology Decline to Disclose 06b false 2024-07-12 false true true false 0 1300000 1300000 0 false 24 0 0 0 false Cirius Therapeutics, Inc. /s/ Mark Olesnavage Mark Olesnavage Interim CEO 2024-08-15